Menu
×
×

Sign Up

Your Profile will be reviewed by Admin
EVENT DATE
Dec 2017
MoTuWeThFrSaSu
    123
45678910
11121314151617
18192021222324
25262728293031
EXPO DATE
Dec 2017
MoTuWeThFrSaSu
    123
45678910
11121314151617
18192021222324
25262728293031

Venue

Henry B. Gonzalez Convention Center 900 East Market Street San Antonio , Texas 78205
Tel: (210) 207-8500
Website
Google Map

CTRC-AACR San Antonio Breast Cancer Symposium 2017 (SABCS)

Overview

Event Overview:

Since 1977, the Symposium’s mission has been to provide state-of-the-art information on breast cancer research. From a one-day regional conference, the Symposium has grown to a five-day program attended by a broad international audience of academic and private researchers and physicians from over 90 countries.

The Symposium aims to achieve a balance of clinical, translational, and basic research, providing a forum for interaction, communication, and education for a broad spectrum of researchers, health professionals, and those with a special interest in breast cancer.

In 2007, the Cancer Therapy & Research Center (CTRC) at UT Health Science Center San Antonio and the American Association for Cancer Research (AACR) announced a collaboration for the future of the San Antonio Breast Cancer Symposium. The Symposium has been renamed the CTRC-AACR San Antonio Breast Cancer Symposium. Complementing the clinical strengths of the highly regarded annual San Antonio Breast Cancer Symposium, the AACR's scientific prestige in basic, translational and clinical cancer research will create a unique and comprehensive scientific meeting that will advance breast cancer research for the benefit of patients.

In 2005, Baylor College of Medicine became a joint sponsor of the symposium and will remain in the CTRC-AACR collaboration.

C. Kent Osborne, MD, Director, Professor of Medicine and Molecular and Cellular Biology, Director, Dan L. Duncan Cancer Center, Baylor College of Medicine, Virginia G. Kaklamani, MD, Professor of Medicine, Division of Hematology/Oncology, UT Health San Antonio and Carlos L. Arteaga, MD, Professor of Medicine and Cancer Biology, Associate Director for Clinical Research, Director Breast Cancer Program Vanderbilt-Ingram Cancer Center, Vanderbilt University are Co-Directors of the Symposium.

Symposium Objective

This Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

Scientific Program

The scientific program consists of plenary lectures and mini-symposia by experts in clinical and basic research; selected slide and poster presentations chosen from the submitted abstracts; educational sessions, award lectures, panel and case discussions and forums. General sessions are approximately 2 hours in duration and are the vehicle for slide presentations, which are allotted 10 minutes each followed by 5 minutes of discussion. Poster sessions are 1 1/2 to 2 hours long.

Target Audience

This international symposium is directed primarily towards academic and private physicians and researchers involved in breast cancer in medical, surgical, gynecologic, and radiation oncology, as well as other appropriate health care professionals.

Financial Philosophy

Any remaining funds at the conclusion of the CME activity will be used for educational research purposes

Exhibitor Information:

SABCS is the world’s most renowned and largest breast cancer meeting.

SABCS exhibits and sponsorships are your best opportunity to communicate directly with leading decision makers and other medical professionals specializing in breast cancer research and treatment.

About CTRC:

The Cancer Therapy & Research Center, or CTRC, is a part of UT Medicine San Antonio - the clinical practice of the School of Medicine at the UT Health Science Center. The CTRC is one of the nation's premier cancer centers and first opened its doors in 1974 as a 501(c)(3) nonprofit corporation dedicated to providing the community with outpatient radiation therapy. More than four decades later, CTRC continues to serve - in a vastly expanded capacity - residents of San Antonio and South Texas, as well as patients from across the U.S., northern Mexico and other countries around the globe.

About AACR:

The AACR is the oldest and largest scientific organization in the world focused on every aspect of high-quality, innovative cancer research. Its reputation for scientific breadth and excellence attract the premier researchers in the field. The programs and services of the AACR foster the exchange of knowledge and new ideas among scientists dedicated to cancer research, provide training opportunities for the next generation of cancer researchers, and increase public understanding of cancer.

Notes:
Sponsorship Details:
Support in any amount is greatly appreciated. Funds received from industry are used in accordance with CME standards to defray expenses related to accredited educational activity.

Agenda

Dec 5   
8:00 am - 7:00 pm REGISTRATION - Main Lobby
   
9:30 am - 11:00 am

CAREER DEVELOPMENT FORUM: A Networking Session for Young Investigators – Room 304 - 3rd Level

Networking and career development opportunities for early career scientists.   This session is open to early-career scientists, defined as graduate students, postdoctoral or clinical fellows, or medical students and residents, who are registered attendees of the 2017 SABCS. 

Space in the workshop is limited to 220 participants; registrations will be accepted on a first-come, first-served basis and is free of charge.  You can register for this session when you register for the Symposium.

   
10:00 am - 11:00 am  CAREER DEVELOPMENT: Cultivating Investigator/Advocate Interactions in Your Research - Room 303 - 3rd Level

Round table discussions sharing best practices and successful collaboration in research and clinical settings.  This session is open to registered attendees of the 2017 SABCS.  

Space is limited to 80 participants; registrations will be accepted on a first-come, first-served basis and is free of charge.  You can register for this session when you register for the Symposium.

   
11:00 am - 12:45 pm

INTERNATIONAL SESSION
Global View of Value Based Medicine - Hemisfair Ballroom 2&3 - 3rd Level
Moderator: Peggy Porter, MD
Fred Hutchinson Cancer Research Center
Seattle, WA

Latin America
Felicia M. Knaul, PhD
University of Miami
Miami, FL 

Middle East
Sana Al Sukhun, MD, MSc
Jordanian Oncology Society
Amman, JORDAN

Breast imaging in Uganda
Constance D. Lehman, MD, PhD
Massachusetts General Hospital
Boston, MA

   
11:00 am - 12:45 pm WORKSHOPS
Molecular Biology in Breast Oncology - Stars at Night Ballroom 1&2 - 3rd Level
Moderator: Carlos L. Arteaga, MD
Vanderbilt University Medical Center
Vanderbilt-Ingram Cancer Center
Nashville, TN
 

Drug target discovery: how to go about it?
Markus Warmuth, MD
H3 Biomedicine
Cambridge, MA

Bench-based approaches to discover mechanisms of drug resistance (i.e. CRISPR, genome library screens, etc.)
Nikhil Wagle, MD
Dana-Farber Cancer Institute
Boston, MA

Genomics & bioinformatics (big data) in breast cancer research
Mia Levy, MD, PhD
Vanderbilt University Medical Center
Nashville, TN

Single cell genomics and tumor heterogeneity
Jorge S. Reis-Filho, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, NY

   
11:00 am - 12:45 pm Methods in Breast Cancer Clinical Research - Stars at Night Ballroom 3&4 - 3rd Level
Moderator: Virginia G. Kaklamani, MD
UT Health San Antonio
San Antonio, TX 
 

Novel statistical clinical trial designs
Yu Shyr, PhD
Vanderbilt Ingram Cancer Center
Nashville, TN

Incorporating biomarkers in clinical trials
Edith Perez, MD
Genentech
South San Francisco, CA

What about neoadjuvant trials and path CR
Hope Rugo, MD
University of California
San Francisco, CA

Regulatory issues
Tatiana M. Prowell, MD
FDA/Johns Hopkins
Silver Spring, MD

   
12:45 pm - 1:00 pm BREAK
   
1:00 pm - 6:00 pm

EDUCATIONAL SESSIONS - Stars at Night Ballrooms 1&2, 3&4 and Hemisfair Ballroom 2&3 - 3rd Level

Updates on advances in key areas and in technologies available for translational research. Many of these sessions will provide attendees with a better understanding of the background leading up to talks they will hear in the succeeding days, and some of the techniques that will be used. These presentations should also provide researchers with ideas and techniques to be considered for their own studies.

 
1:00 pm - 2:30 pm

Shifting Paradigms in Radiation Oncology – Hemisfair Ballroom 2&3 - 3rd Level
Moderator: Richard L. Crownover, MD, PhD
UT Health San Antonio
San Antonio, TX

Accelerated partial breast irradiation: Update of an ASTRO consensus guideline
Candace R. Correa, MD
Community Cancer Center
Normal, IL

Guidelines for postmastectomy radiotherapy
Abram Recht, MD, FASTRO, FASCO
Beth Israel Deaconess Medical Center
Boston, MA                                   

Advanced technologies to optimize outcomes and minimize toxicities
Reshma Jagsi, MD, DPhil
University of Michigan
Ann Arbor, MI

Changing Recommendations for Intermediate Risk Lesions – Stars at Night Ballroom 1&2 - 3rd Level
Moderator: Virginia G. Kaklamani, MD
UT Health San Antonio
San Antonio, TX

The pathology of high risk proliferative lesions of the breast
Kalliopi P. Siziopikou, MD, PhD
Northwestern University
Chicago, IL

Clinical management of women with increased breast cancer risk based on histologic lesions
Amy C. Degnim, MD
Mayo Clinic
Rochester, MN

Managing increased breast cancer risk based on high and moderate penetrance gene mutations
Judy E. Garber, MD, MPH
Dana-Farber Cancer Institute
Boston, MA

Beyond Expression Profiling: RNA Epigenetics – Stars at Night Ballroom 3&4 - 3rd Level
Moderator: Douglas Yee, MD
University of Minnesota
Minneapolis, MN

Drugging protein synthesis in cancer therapy
Robert J. Schneider, PhD
New York University
New York, NY

Targeting RNA splicing in cancer therapy
Stephan Vagner, PhD
Institut Curie-Centre de Recherche
Orsay, FRANCE

Progress, paradigms, and pathways of long non-coding RNAs in cancer
Liuqing Yang, PhD
UT MD Anderson Cancer Center
Houston, TX


2:45 pm - 4:15 pm

Medical Treatment of HER2+++ Breast Cancer – Hemisfair Ballroom 2&3 - 3rd Level
Moderator: Angelo Di Leo, MD, PhD
Hospital of Prato
Prato, ITALY

HER2 testing - 2017 guidelines for HER2 testing
Robert B. Jenkins, MD, PhD
Mayo Clinic
Rochester, MN

Adjuvant HER2+
Ruth M. O'Regan, MD
University of Wisconsin
Madison, WI

Can we improve treatment tailoring in advanced HER2+ breast cancer?
Martine J. Piccart, MD, PhD
Institut Jules Bordet
Brussels, BELGIUM

 

Multi-Level Influences on Breast Cancer Disparities – Stars at Night Ballroom 1&2 - 3rd Level
Moderator: Melissa L. Bondy, PhD
Baylor College of Medicine
Houston, TX

Place as a cause of breast cancer disparities in Appalachia
Electra D. Paskett, BS, MSPH, PhD
Ohio State University
Columbus, OH

Biologic, cultural and health systems influences on breast cancer disparities in Latinas
Amelie G. Ramirez, DrPH
UT Health San Antonio
San Antonio, TX

Biologic and health system determinants of breast cancer disparities in African Americans
Katherine E. Reeder-Hayes, MD
University of North Carolina
Chapel Hill, NC

Panel Discussion

 

The Breast Tumor Microenvironment: A Target for Therapy – Stars at Night Ballroom 3&4 - 3rd Level
Moderator: Leisha A. Emens, MD, PhD
Johns Hopkins University
Baltimore, MD

How tumor metabolism contributes to the immunosuppressive microenvironment
Jeffrey C. Rathmell, PhD
Vanderbilt University
Nashville, TN

Do tumors overcome immune surveillance by blocking dendritic cell development
David G. DeNardo, PhD
Washington University School of Medicine
St. Louis, MO

 

Opportunities for immune therapy and prevention
Robert H. Vonderheide, MD, DPhil
University of Pennsylvania
Philadelphia, PA


4:30 pm - 6:00 pm

Management Controversies in Locoregional Recurrence - Hemisfair Ballroom 2&3 - 3rd Level
Moderator: Irene Wapnir, MD
Stanford Women's Cancer Center
Stanford, CA

Challenges in the management of locoregional recurrence
Monica Morrow, MD
Memorial Sloan Kettering Cancer Center
New York, NY

Local regional recurrence
Richard C. Zellars, MD
Indiana University
Indianapolis, IN

Should all patients with locoregional recurrence receive systemic therapy?
William J. Gradishar, MD
Northwestern University
Chicago, IL

Circulating Tumor Cells and Liquid Biopsies, Translation to Clinical Practice – Stars at Night Ballroom 1&2 - 3rd Level
Moderator: Matthew J. Ellis, MD, PhD
Baylor College of Medicine
Houston, TX

Liquid biopsies in breast cancer - challenges and opportunities
Sarah-Jane Dawson, MBBS (Hons), FRACP, PhD (Cantab)
Peter MacCallum Cancer Centre
Melbourne, AUSTRALIA

Exosome analysis in breast cancer: Clinical translation
Jacqueline F. Bromberg, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, NY

Circulating complexes of stromal and tumor cells in breast cancer metastasis
Dorraya El-Ashry, PhD
University of Miami Miller School of Medicine
Miami, FL

Androgen, Progesterone and Glucocorticoid Receptors: Drivers of Breast Tumor Progression or Reprogramming of Steroid Receptors During Breast Tumor Progression - Stars at Night Ballroom 3&4 - 3rd Level
Moderator: Suzanne A.W. Fuqua, PhD
Baylor College of Medicine
Houston, TX

Role of androgen receptors in both estrogen receptor positive and negative breast cancer
Jennifer K. Richer, PhD
University of Colorado
Aurora, CO

Tracking progesterone receptor actions in breast cancer progression: Jekyll and Hyde
Carol A. Lange, PhD
University of Minnesota
Minneapolis, MN

Modulating glucocorticoid receptor function in breast cancer
Suzanne D. Conzen, MD
University of Chicago
Chicago, IL               

   
6:00 pm - 8:00 pm RECEPTION
   
8:00 pm - 10:00 pm OPEN SATELLITE EVENT hosted by Dr. Neil Love and Research to Practice - Marriott Rivercenter
DATA + PERSPECTIVES: Clinical Investigators Explore the Emerging Role of PARP Inhibition in the Management of Breast Cancer

For more information and to register for this event, please click on the link below:
http://www.researchtopractice.com/Meetings/PARP2017
Dec 6   
7:00 am - 5:15 pm

REGISTRATION - Main Lobby

   
7:00 am - 8:00 am CONTINENTAL BREAKFAST - Hall 2
   
8:00 am - 8:30 am

WELCOME AND OPENING REMARKS - Hall 3
C. Kent Osborne, MD
Baylor College of Medicine
Houston, TX

   
 8:30 am - 9:00 am SABCS 40th Anniversary Award Lecture: Past and Future of Cancer Drug Development
Richard Pazdur, MD
US Food and Drug Administration
Silver Spring, MD
   
9:00 am - 9:30 am

PLENARY LECTURE 1 - Hall 3

Potential of Radiation Therapy to Convert the Tumor into an In Situ Vaccine
Silvia C. Formenti, MD
Weill Cornell Medicine
New York, NY

9:30 am - 11:15 am

GENERAL SESSION 1 - Hall 3

   
11:00 am - 5:00 pm EXHIBITS - Exhibit Hall 2
   
11:15 am - 12:00 pm

WILLIAM L. MCGUIRE MEMORIAL LECTURE – Hall 3
TBD
Sir Richard Peto, FRS
University of Oxford
Oxford, UNITED KINGDOM

   
12:00 pm - 1:00 pm

BREAK

   
1:00 pm - 2:00 pm

CLINICAL SCIENCE FORUM - Stars at Night Ballroom 1&2 - 3rd Level
Controversies in the Adjuvant Treatment of ER+ Breast Cancer
Moderator: Matthew P. Goetz, MD
Mayo Clinic
Rochester, MN

Adjuvant endocrine therapy for premenopausal ER+ breast cancer
Prudence A. Francis, MBBS, B Med Sc, FRACP, MD
Peter MacCallum Cancer Centre
Melbourne, AUSTRALIA

Searching for the optimal duration of adjuvant endocrine therapy in breast cancer
Vered Stearns, MD
Johns Hopkins University
Baltimore, MD

   
1:00 pm - 2:00 pm

BASIC SCIENCE FORUM 1 - Stars at Night Ballroom 3&4 - 3rd Level
Targeting the Tumor Immune Microenvironment
Moderator: Xiang Zhang, PhD
Baylor College of Medicine
Houston, TX

TBD
Cynthia A. Zahnow, PhD
Johns Hopkins University
Baltimore, MD

Myeloid-derived suppressor cells: many facets of regulation of tumor progression
Dmitry I. Gabrilovich, MD, PhD
The Wistar Institute
Philadelphia, PA

   
 1:00 pm - 2:00 pm EDUCATIONAL SESSION - Hemisfair Ballroom 2&3 - 3rd Level
Ex-vivo Modeling of Breast Cancer
Moderator: Carlos L. Arteaga, MD
Vanderbilt University Medical Center
Vanderbilt-Ingram Cancer Center
Nashville, TN


Organoids as a novel platform for breast cancer research
Oded Kopper, PhD
Hubrecht Institute
Utrecht, NETHERLANDS


Breast cancer patient-derived xenografts as models for metastatic progression and therapeutic response
Alana L. Welm, PhD
University of Utah
Salt Lake City, UT


Genetic dissection of cancer development, therapy response, and resistance in mouse models of breast cancer
Jos Jonkers, PhD
Netherlands Cancer Institute
Amsterdam, NETHERLANDS

   
2:15 pm - 3:15 pm

SUSAN G. KOMEN® BRINKER AWARDS FOR SCIENTIFIC DISTINCTION LECTURES - Hall 3

SUSAN G. KOMEN® BRINKER AWARD FOR SCIENTIFIC DISTINCTION IN BASIC SCIENCE
TBD

SUSAN G. KOMEN® BRINKER AWARD FOR SCIENTIFIC DISTINCTION IN CLINICAL RESEARCH  

TBD

   
3:15 pm - 5:00 pm

GENERAL SESSION 2 - Hall 3

   
5:00 pm - 7:00 pm Spotlight on Cancer Predisposition, Somatic Changes, and Genetic Testing - Stars at Night Ballroom 1&2 - 3rd Level
   
5:00 pm - 7:00 pm Spotlight on Innovations of SLN Mapping + Imaging - Stars at Night Ballroom 3&4 - 3rd Level
   
5:00 pm - 7:00 pm

POSTER SESSION 1 & Reception - Hall 1 

   
7:30 pm - 10:00 pm  OPEN SATELLITE EVENT hosted by Dr. Neil Love and Research to Practice - Marriott Rivercenter
Cases from the Community: Clinical Investigators Provide Their Perspectives on Emerging Research and Actual Patients with Breast Cancer 

For more information and to register for this event, please click on the link below:
http://www.researchtopractice.com/Meetings/SA2017
Dec 7   
7:00 am - 5:15 pm

REGISTRATION - Main Lobby

   
7:00 am - 9:00 am Spotlight on Novel Drugs / Predicting Response for HER2+ Breast Cancer - Stars at Night Ballroom 1&2 - 3rd Level
   
7:00 am - 9:00 am Spotlight on Endocrine Resistance Mediated by CDK4/6, FGFR, and PI3K - Stars at Night Ballroom 3&4 - 3rd Level
   
7:00 am - 9:00 am

POSTER SESSION 2 & continental breakfast - Hall 1

   
9:00 am - 9:30 am

PLENARY LECTURE 2 - Hall 3
Advances in the Understanding of Mutational Signatures in Human Cells
Serena Nik-Zainal, MD, PhD
The Wellcome Trust Sanger Institute
Cambridge, UNITED KINGDOM

   
9:30 am - 11:30 am

GENERAL SESSION 3 - Hall 3

   
11:00 am - 5:00 pm Exhibits - Hall 2
   
11:30 am - 12:00 pm AACR DISTINGUISHED LECTURESHIP IN BREAST CANCER RESEARCH - Hall 3
Leveraging Preclinical Models of Breast Cancer
Jeffrey M. Rosen, PhD
Baylor College of Medicine
Houston, TX
   
12:00 pm - 1:00 pm BREAK
   
1:00 pm - 2:00 pm

CASE DISCUSSION 1 - Stars at Night Ballroom 1&2 - 3rd Level
Moderator: Mothaffar Rimawi, MD
Baylor College of Medicine
Houston, TX

   
1:00 pm - 2:00 pm

BASIC SCIENCE FORUM 2 - Stars at Night Ballroom 3&4 - 3rd Level
Mechanisms of Early Dissemination and Metastasis
Moderator: Julio A. Aguirre-Ghiso, PhD
Mount Sinai School of Medicine
New York, NY

Oncogenic and microenvironmental signals driving early dissemination, dormancy and metastasis
Julio A. Aguirre-Ghiso, PhD
Mount Sinai School of Medicine
New York, NY

The perivascular niche protects dormant disseminated tumor cells from therapy
Cyrus M. Ghajar, PhD
Fred Hutchinson Cancer Research Center
Seattle, WA

   
 1:00 pm - 2:00 pm EDUCATIONAL SESSION - Hemisfair Ballroom 2&3 - 3rd Level
Challenges in Advanced/Metastatic Breast Cancer (ABC)
Moderator: Fatima Cardoso, MD
Champalimaud Clinical Centre
Lisbon, PORTUGAL

Introduction: Where there is controversy, let it be guidance
Fatima Cardoso, MD
Champalimaud Clinical Centre
Lisbon, PORTUGAL

Luminal ABC: optimal use of all available options?
Angela M. DeMichele, MD, MSCE
University of Pennsylvania
Philadelphia, PA

Local therapy of limited disease in ABC: what is the evidence?
Seema A. Khan, SM, MB
Northwestern University
Chicago, IL

Novel approaches for selection and monitoring treatment
Prof. Dr. Carsten Denkert
Charite Berlin
Berlin, GERMANY

Balancing active treatment and palliative care in ABC patients
Thomas J. Smith, MD
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, MD
   
 2:15 pm - 3:15 pm MINI-SYMPOSIUM 1 - Hall 3
Molecular Subtypes and Clinical Ramifications of TNBC
Moderator: Tiffany A. Traina, MD
Memorial Sloan Kettering Cancer Center
New York, NY
 

Targeting genomes in triple negative breast cancer
Samuel Aparicio, PhD
The University of British Columbia
Vancouver, CANADA

New clinical approaches for TNBC
Melinda Telli, MD
Stanford University School of Medicine
Stanford, CA

   
3:15 pm - 5:00 pm

GENERAL SESSION 4 - Hall 3

   
5:00 pm - 7:00 pm Spotlight on Endocrine Therapy - Stars at Night Ballroom 1&2 - 3rd Level
   
5:00 pm - 7:00 pm  Spotlight on Immuno Oncology - Stars at Night Ballroom 3&4 - 3rd Level
   
5:00 pm - 7:00 pm

POSTER SESSION 3 & Reception - Hall 1

 7:30 pm - 10:00 pm 
 
OPEN SATELLITE EVENT presented by Medscape Oncology - Marriott Rivercenter
The Promise of PARP Inhibitors in Metastatic Breast Cancer: New Data, New Treatments?
7:30 pm - 10:00 pm OPEN SATELLITE EVENT presented by Prime Oncology - Marriott Rivercenter
Hope on the Horizon for Triple Negative Breast Cancer
Dec 8   
7:00 am - 5:15 pm

REGISTRATION - Main Lobby

   
7:00 am - 9:00 am Spotlight on Cost Effectiveness / Male Breast Cancer / Fertility - Stars at Night Ballroom 1&2 - 3rd Level
   
7:00 am - 9:00 am  Spotlight on Landscape of Mutations in Metastatic Breast Cancer - Stars at Night Ballroom 3&4 - 3rd Level
   
7:00 am - 9:00 am

POSTER SESSION 4 & continental breakfast - Hall 1

   
9:00 am - 9:30 am

PLENARY LECTURE 3 - Hall 3
Individualizing Management of the Axillary Nodes
Tari A. King, MD
Dana-Farber Cancer Institute
Boston, MA

   
9:30 am - 11:30 am

GENERAL SESSION 5 - Hall 3

   
11:00 am - 5:00 pm EXHIBITS - Hall 2
   
11:30 am- 12:00 pm

AACR OUTSTANDING INVESTIGATOR AWARD FOR BREAST CANCER RESEARCH FUNDED BY SUSAN G. KOMEN® - Hall 3
TBD

   
12:00 pm - 1:00 pm

BREAK

   
1:00 pm- 2:00 pm

CASE DISCUSSION 2 - Stars at Night Ballroom 1&2 - 3rd Level
Moderator: Mothaffar Rimawi, MD
Baylor College of Medicine
Houston, TX

   
1:00 pm - 2:00 pm

BASIC SCIENCE FORUM 3 – Stars at Night Ballroom 3&4 - 3rd Level
Intratumoral Heterogeneity: Clinical Implications from Basic Science
Moderator: Elaine R. Mardis, PhD
Nationwide Children's Hospital
Columbus, OH

Manifestations and implications of subclonal alterations in metastatic breast cancer
Sarat Chandarlapaty, PhD
Memorial Sloan Kettering Cancer Center
New York, NY

Breast cancer heterogeneity landscapes
Charles Perou, PhD
The University Of North Carolina At Chapel Hill
Chapel Hill, NC

   
 1:00 pm - 2:00 pm DEBATE - Hemisfair Ballroom 2&3 - 3rd Level
This house believes that all women diagnosed with metastatic breast cancer should undergo next generation sequencing?
Chairman: Eric P. Winer, MD
Dana-Farber Cancer Institute
Boston, MA 
 

Funda Meric-Bernstam, MD
UT MD Anderson Cancer Center
Houston, TX

Fabrice André, MD, PhD
Institut Gustave Roussy
Villejuif, FRANCE

   
2:15 pm - 3:15 pm

MINI-SYMPOSIUM 2 - Hall 3

Lobular Breast Cancer - Is it a Different Disease?
Moderator: Otto Metzger, MD
Dana-Farber Cancer Institute
Boston, MA

Pathology and genomics of lobular breast carcinomas and their precursors
Jorge S. Reis-Filho, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, NY

Understanding the unique biology of ILC
Steffi Oesterreich, PhD
University of Pittsburgh
Pittsburgh, PA

Tailoring systemic therapy for patients with lobular breast cancer
Marco A. Colleoni, MD
European Institute of Oncology
Milano, ITALY

   
3:15 pm - 5:00 pm

GENERAL SESSION 6 - Hall 3

   
5:00 pm - 7:00 pm

POSTER SESSION 5 & Reception - Hall 1 

   
5:00 pm - 7:00 pm

SPECIAL SESSION
View from the Trenches: What Will You Do On Monday Morning? - Stars at Night Ballroom 3&4 - 3rd Level
Moderator: Lisa A. Carey, MD
University of North Carolina at Chapel Hill
Chapel Hill, NC

Panel Members:

Matthew J. Ellis, MD, PhD
Baylor College of Medicine
Houston, TX

Susan G. Hilsenbeck, PhD
Baylor College of Medicine
Houston, TX

Patricia Spears, BS
University of North Carolina
Chapel Hill, NC

Steven E. Vogl, MD
Montefiore Medical Center
Bronx, NY

Eric P. Winer, MD
Dana-Farber Cancer Institute
Boston, MA

Dec 9   
7:00 am - 9:00 am

Registration - Main Lobby

   
7:00 am - 9:00 am POSTER SESSION 6 & continental breakfast - Hall 1
   
9:00 am - 11:00 am

The Year in Review - Hall 3

Moderator: C. Kent Osborne, MD
Baylor College of Medicine
Houston, TX

Basic science
Ramon Parsons, MD, PhD
Icahn School of Medicine at Mount Sinai
New York, NY

Translational research
Nicholas C. Turner, PHD, FRCP, BM, MA
The Royal Marsden Hospital
London, UNITED KINGDOM

Early breast cancer in review
Antonio C. Wolff, MD, FACP, FASCO
Johns Hopkins University
Baltimore, MD

Advanced and metastatic breast cancer
Nancy Lin, MD
Dana-Farber Cancer Institute
Boston, MA

   
11:00 am Adjournment

Photos +

RELATED EVENTS +

MORE events +

Display Makers +

Promo Makers +

Other Services Providers